This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jo, H.
Right arrow Articles by Luo, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jo, H.
Right arrow Articles by Luo, H. R.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2008, p. 4285-4299, Vol. 28, No. 13
0270-7306/08/$08.00+0     doi:10.1128/MCB.01240-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation{triangledown} ,{dagger}

Hakryul Jo, Yonghui Jia, Kulandayan K. Subramanian, Hidenori Hattori, and Hongbo R. Luo*

Department of Pathology, Harvard Medical School, Dana-Farber/Harvard Cancer Center, Department of Laboratory Medicine, Stem Cell Program, Joint Program in Transfusion Medicine, Children's Hospital Boston, Boston, Massachusetts

Received 11 July 2007/ Returned for modification 8 October 2007/ Accepted 2 May 2008

Cancer cells in their respective microenvironments must endure various growth-constraining stresses. Under these conditions, the cancer cell-derived factors are thought to modulate the signaling pathways between cell growth and dormancy. Here, we describe a cancer cell-derived regulatory system that modulates the phosphatidylinositol 3'-kinase (PI3K)-Akt pathway under serum deprivation stress. Through the use of biochemical purification, we reveal that cancer cell-secreted insulin-like growth factor 1 (IGF-1) and clusterin, an extracellular stress protein, constitute this regulatory system. We show that secreted clusterin associates with IGF-1 and inhibits its binding to the IGF-1 receptor and hence negatively regulates the PI3K-Akt pathway during serum deprivation. This inhibitory function of clusterin appears to prefer IGF-1, as it fails to exert any effects on epidermal growth factor signaling. We demonstrate furthermore that the constitutive activation of oncogenic signaling downstream of IGF-1 confers insensitivity to the inhibitory effects of clusterin. Thus, the interplay between cancer cell-derived clusterin and IGF-1 may dictate the outcome of cell growth and dormancy during tumorigenic progression.

* Corresponding author. Mailing address: Karp Family Research Building, Room 10214, 1 Blackfan Circle, Boston, MA 02115. Phone: (617) 919-2303. Fax: (617) 730-0885. E-mail: Hongbo.Luo{at}childrens.harvard.edu

{triangledown} Published ahead of print on 5 May 2008.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

Molecular and Cellular Biology, July 2008, p. 4285-4299, Vol. 28, No. 13
0270-7306/08/$08.00+0     doi:10.1128/MCB.01240-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»